Viral Clearance Strategies for Biopharmaceutical Safety

Viral Clearance Strategies for Biopharmaceutical Safety

June 2, 2001

Publication

Article

Pharmaceutical TechnologyPharmaceutical Technology-06-02-2001

Volume 25

Issue 6

Special considerations and cautions must be adhered to when designing virus safety studies and developing appropriate virus contamination control programs.

External Link - article-22567.pdf

Articles in this issue

Measurement of Intrinsic Drug Dissolution Rates Using Two Types of Apparatus

A Systematic Evaluation of the Compression and Tablet Characteristics of Various Types of Lactose and Dibasic Calcium Phosphate

Viral Clearance Strategies for Biopharmaceutical Safety

Outsourcing Outlook

Managing Risks and Resources

Blister News: COC Resin, Foil, and Lidding Innovations

Managing the Risks in Outsourcing

Systemic Drug Delivery via the Buccal Mucosal Route

Related Content

Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com

Circio and Certest to Collaborate on LNP Formulations

Feliza Mirasol

November 21st 2024

Article

The companies will collaborate to create and test circVec DNA–LNP formulations for use in potential therapeutic applications.

Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Felicity Thomas

June 25th 2024

Podcast

In this episode, Hanns-Christian Mahler from ten23 Health chats about the advances in fill/finish.

CDMO SEKISUI Expands its CGMP Biopharma Manufacturing Capacity

Feliza Mirasol

November 20th 2024

Article

SEKISUI has used a £15.7 million (US$20.7 million) investment to expand its clinical-grade drug substance manufacturing at its UK site.

Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines

Feliza Mirasol

April 30th 2024

Podcast

In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.

Frontier Scientific Solutions Plans a Global Free Trade Zone Gateway to Supply Life Sciences Industry on Back of $1.5 Billion Investment

Feliza Mirasol

November 16th 2024

Article

Frontier Scientific Solutions has unveiled plans to use a $1.5 billion commitment from a major investor to create a global free trade zone gateway to facilitate the life sciences supply chain using Wilmington International Airport in North Carolina.